1. Антонов А.Г., Никитина И.В., Митрохин С.Д. Клинические рекомендации по профилактике и лечению грибковых инфекций у новорождённых в условиях отделения реанимации и интенсивной терапии // Неонатология: новости, мнения, обучение. 2013. № 1. P. 80–88. 2. Veerdonk F.L. Van De, Kullberg B., Netea M.G. Pathogenesis of invasive candidiasis // Curr. Opin. Crit. Care. 2010. № 16. P. 453–459. 3. Gow N.A.R. et al. Candida albicans morphogenesis and host defence: discriminating invasion from colonization // Nat. Rev. Microbiol. 2013. Vol. 10, № 2. P. 112–122. 4. Austin N., Mcguire W. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants (Review) // Cochrane Database Syst. Rev. 2013. № 4. 5. Greenberg R.G. et al. Emperic Antifungal Therapy and Outcomes in Extremely-LowBirth-Weight Infants with Invasive Candidiasis // Pediatrics. 2012. Vol. 161, № 2. P. 264– 269. 6. Никитина И.В., Ионов О.В., Приходько Н.А. Современные подходы к диагностике, терапии и профилактике инвазивных микозов у новорождённых // Неонатология: новости, мнения, обучение. 2014. Vol. 4. P. 64–72. 7. Gaitanis G. et al. The Malassezia Genus in Skin and Systemic Diseases // Clin. Microbiol. Rev. 2012. Vol. 25, № 1. P. 106–141. 8. Chen Y. et al. International Journal of Antimicrobial Agents Echinocandins vs . Amphotericin B against invasive candidiasis in children and neonates : A meta-analysis of randomized controlled trials // Int. J. Antimicrob. Agents. Elsevier B.V., 2019. Vol. 53, № 6. P. 789–794. 9. Dowling D. et al. Malassezia furfur Emergence and Candidemia Trends in a Neonatal Intensive Care Unit During 10 Years // Adv. Neonatal Care. 2014. Vol. 00, № 0. P. 1–6. 10. Calley J.L., Warris A. Recognition and diagnosis of invasive fungal infections in neonates // J. Infect. Elsevier Ltd, 2017. Vol. 74. P. S108–S113. 27 11. Никитина И.В. et al. Инвазивные микозы в неонатологии: профилактика, диагностика и терапия // Акушерство и гинекология. 2015. № 4. P. 84–90. 12. Martin R.J., Fanaroff A.A., Walsh M.C. Neonatal-Perinatal Medicine // Diseases of the Fetus and Infant. Eleventh E. Elsevier Inc., 2019. Vol. 2, 11th Ed. 13. Yuan G. et al. Successful fluconazole combined with caspofungin treatment of candida bloodstream infection in preterm infant // Clin. Case Rep. 2021. Vol. 100, № 52. P. 1–2. 14. Ионов О.В., Никитина И.В., Приходько Н.А. Особенности микробной колонизации новорождённых в отделении реанимации и интенсивной терапии // Инфекционные болезни. 2013. Vol. 3. P. 87–91. 15. Clark R.H. et al. Changes in the Incidence of Candidiasis in Neonatal Intensive Care Units // Pediatrics. 2014. Vol. 133, № 2. P. 236–242. 16. Greenberg R.G., Benjamin, Jr. D.K. Neonatal candidiasis: diagnosis, prevention and treatment // Infections. 2014. Vol. 69, № 0 1. P. 1–8. 17. Benjamin D.K. et al. Neonatal Candidiasis Among Extremely Low Birth Weight Infants: Risk Factors , Mortality Rates , and Neurodevelopmental Outcomes at 18 to 22 Months // Pediatrics. 2006. Vol. 117, № 1. P. 84–92. 18. Zaoutis T.E. et al. Outcomes Attributable to Neonatal Candidiasis // Infect. Dis. (Auckl). 2007. № 44. P. 1187–1193. 19. Bersani I. et al. Antifungal Drugs for Invasive Candida Infections (ICI) in Neonates: Future Perspectives // Front. Pediatr. 2019. Vol. 7, № September. P. 1–10. 20. Климко Н.Н. et al. Диагностика и лечение микозов в отеделениях реанимации и интенсивной терапии. Российские рекомендации. 2015. 1–49 p. 21. Pappas P.G. et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America // Clin. Infect. Dis. 2016. Vol. 62. P. 1–50. 22. Hope W.W. et al. ESCMID * guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp . // Clin. Microbiol. Infect. 2012. Vol. 18, № 7. P. 38–52. 28 23. Самсыгина Г.А. Кандидоз у новорождённых // Медицинская сестра. 2009. № 8. P. 14. 24. Kaufman D.A. Fungal Infections in Preterm Infants // Medscape. 2014. P. 980487. 25. Kaufman D.A., Manzoni P. Strategies to Prevent Invasive Candidal Infection in Extremely Preterm Infants // Clin. Perinatol. Elsevier Ltd, 2010. Vol. 37, № 3. P. 611– 628. 26. Веселов А.В., Козлов Р.С. Инвазивный кандидоз: современные аспекты эпидемиологии, диагностики, терапии и профилактики у различных категорий пациентов Содержание. 2016. 1–104 p. 27. Hospenthal D.R., Rinaldi M.G. Diagnosis and treatment of human mycoses. 2013. Р 16– 18. 28. Ascher S.B. et al. Antifungal Therapy and Outcomes in Infants with Invasive Candida Infections // Pediatr. Infect. Disiease. 2013. Vol. 31, № 5. P. 439–443. 29. Приходько Н.А. et al. Применение препарата микафунгин при лечении инвазивных кандидозов у недоношенных детей в условиях отделения реанимации и интенсивной терапии новорождённых // Неонатология: новости, мнения, обучение. 2015. № 4. P. 84–90. 30. Barton M. et al. Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls // BMC Infect. Dis. 2014. Vol. 14, № 1. P. 1–10. 31. Thomas-rüddel D.O. et al. Risk Factors for Invasive Candida Infection in Critically Ill Patients A Systematic Review and Meta-analysis // Chest. The Author(s), 2021. Vol. 161, № 2. P. 345–355. 32. Filippidi A. et al. The effect of maternal flora on Candida colonisation in the neonate. 2014. P. 43–48. 33. Zisova L.G. et al. Vulvovaginal Candidiasis in Pregnant Women and its Importance for Candida Colonization of Newborns // Folia Med. 2016. Vol. 58, № 2. P. 108–114. 34. Pérez-ayala A., Blázquez-gamero D. Revista Iberoamericana de Micología Congenital 29 cutaneous candidiasis associated with maternal peripartum candidemia. 2020. Vol. 37, № 2. P. 68–71. 35. Avni T., Leibovici L., Paul M. PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis // J. Clin. Microbiol. 2011. Vol. 49, № 2. P. 665–670. 36. Peman J., Zaragoza R. Current diagnostic approaches to invasive candidiasis in critical care settings // Mycoses. 2009. Vol. 53. P. 424–433. 37. Tragiannidis A., Tsoulas C., Groll A.H. Invasive candidiasis and candidaemia in neonates and children: update on current guidelines // Mycoses. 2014. P. 1–12. 38. Bromiker R. et al. Do Neonatal Infections Require a Positive Blood Culture? // Am. Jiurnal Perinatol. 2020. Vol. 37, № 52. P. 18–21. 39. Yaacobi N., Bar-meir M., Bromiker R. A Prospective Controlled Trial of the Optimal Volume for Neonatal Blood Cultures // Pediatr. Infect. Disiease. 2015. Vol. 34, № 4. P. 351–354. 40. Hsieh Y.C. et al. Short time to positivity of blood culture predicts mortality and septic shock in bacteremic patients: a systematic review and meta ‑ analysis // BMC Infect. Dis. BioMed Central, 2022. P. 1–18. 41. Cardozo C. et al. An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia // J. Antimicrob. Chemother. 2019. Vol. 75, № 3. P. 1–8. 42. Припутневич Т.В. et al. Прямая идентификация микроорганизмов из гемокультур с помощью метода MALDI-TOF-MS в сравнении с методом ПЦР // Клиническая микробиология и антимикробная химиотерапия. 2014. Vol. 16, № 1. P. 21–26. 43. Georgescu T.I.A.U. et al. Congenital systemic candidiasis: a comprehensive literature review and meta-analysis of 44 cases // Rom. J. Morphol. Embryol. 2020. Vol. 61, № 3. P. 673–680. 44. Pana Z., Kougia V., Roilides E. Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients: an update // Expert Opin. Pharmacother. 2015. Vol. 16, № 5. P. 1–18. 45. Calderaro A. et al. Comparison of peptide nucleic acid fluorescence in situ hybridization 30 assays with culture-based matrix-assisted laser desorption / ionization-time of flight mass spectrometry for the identification of bacteria and yeasts from blood cultures and cerebrospi // Clin. Microbiol. Infect. European Society of Clinical Infectious Diseases, 2014. Vol. 20, № 8. P. O468–O475. 46. Chaussade H. et al. Original Article Central nervous system candidiasis beyond neonates: Lessons from a nationwide study. 2020. P. 266–277. 47. Manzoni P. et al. Fungal and bacterial sepsis and threshold ROP in preterm very low birth weight neonates // J. Perinatol. 2006. № 26. P. 23–30. 48. Campbell J. et al. Use of Potassium Hydroxide (KOH) Test Reduces Antifungal Medication Prescription for Suspected Monilial Diaper Dermatitis in the Neonatal Intensive Care Unit // Clin. Issues Neonatal Care. 2019. Vol. 19, № 6. P. 3–10. 49. Kauffman C.A. Diagnosis and Management of Fungal Urinary Tract Infection // Infect. Dis. Clin. NA. Elsevier Inc, 2014. Vol. 28, № 1. P. 61–74. 50. Kauffman C.A. et al. Candida Urinary Tract Infections — Diagnosis. 2011. Vol. 52, № Suppl 6. 51. Cariou G. et al. Recommandations du comité d ’ infectiologie de l ’ AFU . Diagnostic , traitement et suivi des candiduries Recommendations of the infectious disease committee of the French // Prog. en Urol. Elsevier Masson SAS, 2011. Vol. 21, № 5. P. 314–321. 52. Nejad E.E. et al. Molecular identification of Candida isolates by Real-time PCR-highresolution melting analysis and investigation of the genetic diversity of Candida species // J. Clin. Lab. Anal. 2020. Vol. 34, № e234444. P. 1–8. 53. Asadzadeh M., Ahmad S., Ziauddin N.A. Rapid and Accurate Identification of Candida albicans and Candida dubliniensis by Real-Time PCR and Melting Curve Analysis // Med. Princ. gractice. 2018. Vol. 13110. P. 543–548. 54. Chen Y. et al. Clinical and Microbiological Characteristics of Neonates with Candidemia and Impacts of Therapeutic Strategies on the Outcomes // J. Fungi. 2022. Vol. 8, № 465. P. 1–12. 55. Tamelyt E., Jankauskait L. Early Blood Biomarkers to Improve Sepsis / Bacteremia Diagnostics in Pediatric Emergency Settings // Medicina (B. Aires). 2019. Vol. 55, № 99. 31 P. 1–13. 56. Martins E.C. et al. Neutrophil-lymphocyte ratio in the early diagnosis of sepsis in an intensive care unit: A case-control study // Rev. Bras. Ter. Intensiva. 2019. Vol. 31, № 1. P. 63–70. 57. Chabot-Richards D.S., George T.I. White Blood Cell Counts. Reference Methodology. // Clin. Lab. Med. Elsevier Inc, 2015. Vol. 35, № 1. P. 11–24. 58. Russell C.D. et al. The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: A systematic review and meta-analysis // J. Infect. 2020. № January. 59. Valeska J. et al. Assessment of C-Reactive Protein Diagnostic Test Accuracy for LateOnset Infection in Newborn Infants A Systematic Review and Meta-analysis // JAMA Pediatr. 2020. P. 1–9. 60. Brown J.V.E. et al. C-reactive protein for diagnosing late-onset infection in newborn infants // Cochrane Database Syst. Rev. 2019. Vol. 2019, № 1. 61. Benjamin D.K. et al. Neonatal Candidemia and End-Organ Damage: A Critical Appraisal of the Literature Using Meta-analytic Techniques // Pediatrics. 2003. Vol. 112, № 3. P. 634–640. 62. Warris A. et al. ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children // Clin. Microbiol. Infect. Elsevier Ltd, 2019. Vol. 25, № 9. P. 1096–1113. 63. Ferreras-Antolín L., Sharland M., Warris A. Management of Invasive Fungal Disease in Neonates and Children // Pediatr. Infect. Disiease. 2020. Vol. 38. P. 1–13. 64. Bharwani S., Dhanireddy R. Systemic fungal infection is associated with the development of retinopathy of prematurity in very low birth weight infants: a meta-review // J. Perinatol. 2008. № 28. P. 61–66. 65. Huang C. Central Nervous System Candidiasis in Very Premature Neonates and Infants : US Characteristics and Histopathologic and MR Imaging Correlates in Five so // Pediatr. Imaging. 1998. Vol. 209. P. 49–56. 66. Kaufman D.A. et al. Congenital Cutaneous Candidiasis: Prompt Systemic Treatment Is 32 Associated With Improved Outcomes in Neonates // Clin. Infect. Dis. 2017. Vol. 64, № 10. P. 1387–1395. 67. Blume-peytavi U., Kanti V. Prevention and treatment of diaper dermatitis // Pediatr. Dermatol. 2018. № 35. P. 19–23. 68. Siki M. et al. Diagnosis and management of diaper dermatitis in infants with emphasis on skin microbiota in the diaper area c Poga c eti c a Mar c // Int. J. Dermatol. 2018. № 57. P. 265–275. 69. Jagtap S.A., Saple P.P., Dhaliat S.B. Congenital cutaneous candidiasis: A rare and unpredictable disease Introduction // Indian J. Dermatol. 2011. Vol. 56, № 1. P. 92–94. 70. Egunsola O., Adefurin A. Safety of fluconazole in paediatrics: a systematic review // Eur. J. Clin. Pharmacol. 2013. Vol. 69. P. 1211–1221. 71. Шухов В.С. et al. Антимикробная терапия у детей. 2016. 1–305 p. 72. Oeser C. et al. Neonatal invasive fungal infection in England 2004 – 2010 // Clin. Microbiol. Infect. 2014. № 20. P. 936–941. 73. Iosifidis E., Papachristou S., Roilides E. Advances in the Treatment of Mycoses in Pediatric Patients // J. Fungi. 2018. Vol. 4, № 115. P. 1–25. 74. Tsekoura M. et al. Efficacy and Safety of Echinocandins for the Treatment of Invasive Candidiasis in Children: A Meta-Analysis // Pediatr. Infect. Dis. J. 2018. Vol. 38, № 1. P. 42–49. 75. Riosa J.F. da S. et al. Fluconazole prophylaxis in preterm infants: a systematic review // Brazilian J. Infect. Dis. Sociedade Brasileira de Infectologia, 2017. № x x. P. 6–11. 76. Autmizguine J. et al. Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants // J. Antimicrob. Chemother. 2018. P. 1–6. 33